ConductScience.org, home

Paper33145451

Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis.

Bhatia A and 4 others. Contemp Clin Trials Commun, 2020. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis. Papers, record 33145451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33145451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of efficacy and safety of a novel lipogel containing diclofenac: A randomized, placebo controlled, double-blind clinical trial in patients with signs and symptoms of osteoarthritis.
PubMed
Journal
Contemp Clin Trials Commun
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2022-04-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bhatia AAmit
2Goni VVijay
3Chopra SShruti
4Singh BBhupinder
5Katare OPOm Prakash

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131334187A cross-sectional study to screen community health volunteers for hip/knee-osteoarthritis and osteoporosis.J Family Med Prim Care2019https://conductscience.org/library/papers/31334187PubMed
212897215Osteoarthritis.Postgrad Med J2003https://conductscience.org/library/papers/12897215PubMed
325457327Total knee replacement in acute and chronic traumatic events.Injury2014https://conductscience.org/library/papers/25457327PubMed
416086839Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886].BMC Musculoskelet Disord2005https://conductscience.org/library/papers/16086839PubMed
524692832
Comparative assessment of the effectiveness and tolerability of lornoxicam 8 mg BID and diclofenac 50 mg TID in adult indian patients with osteoarthritis of the hip or knee: A 4-week, double-blind, randomized, comparative, multicenter study.
Curr Ther Res Clin Exp2009https://conductscience.org/library/papers/24692832PubMed
616331769Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee.J Rheumatol2005https://conductscience.org/library/papers/16331769PubMed
721811391Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis.J Pain Res2011https://conductscience.org/library/papers/21811391PubMed
819850095Nanotechnology and the transdermal route: A state of the art review and critical appraisal.J Control Release2010https://conductscience.org/library/papers/19850095PubMed
915020333The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study.Ann Rheum Dis2004https://conductscience.org/library/papers/15020333PubMed
1015608303Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale.Ann Rheum Dis2005https://conductscience.org/library/papers/15608303PubMed
1111014340Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines.Arthritis Rheum2000https://conductscience.org/library/papers/11014340PubMed
1220615093Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin.J Drug Target2011https://conductscience.org/library/papers/20615093PubMed
1317363401Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.Ann Rheum Dis2007https://conductscience.org/library/papers/17363401PubMed
1432086778Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review.Rheumatol Ther2020https://conductscience.org/library/papers/32086778PubMed
1519817509The economic burden of osteoarthritis.Am J Manag Care2009https://conductscience.org/library/papers/19817509PubMed
1616808554Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.Drug Saf2006https://conductscience.org/library/papers/16808554PubMed
1726720629Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies.Clin Cardiol2016https://conductscience.org/library/papers/26720629PubMed
1827755265Measures for Pain and Function Assessments for Patients With Osteoarthritis.J Am Acad Orthop Surg2016https://conductscience.org/library/papers/27755265PubMed
1915742450What WOMAC pain score should make a patient eligible for a trial in knee osteoarthritis?J Rheumatol2005https://conductscience.org/library/papers/15742450PubMed
2024393558Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications.J Pharm Pharm Sci2013https://conductscience.org/library/papers/24393558PubMed

See all 34 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41795066Advancement on localized targeting via intra-articular administration of lipid-based vesicular nanoparticles for osteoarthritis management.J Nanobiotechnology2026https://conductscience.org/library/papers/41795066PubMed
36836078Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022).J Clin Med2023https://conductscience.org/library/papers/36836078PubMed
36031671Exploration of novel drug delivery systems in topical management of osteoarthritis.Drug Deliv Transl Res2023https://conductscience.org/library/papers/36031671PubMed
36003519Therapeutic potential of nanotechnology-based approaches in osteoarthritis.Front Pharmacol2022https://conductscience.org/library/papers/36003519PubMed
34951922New developments in osteoarthritis pharmacological therapies.Rheumatology (Oxford)2021https://conductscience.org/library/papers/34951922PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33145451

GET https://conductscience.org/api/papers/v1/33145451/references?page=2